NTRA Natera, Inc.
Natera, Inc. (NTRA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $5.9M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Sheena Jonathan 12 fills | Director | Sell 10b5-1 | 18,064 | $388.01 | $7.0M | 17,642 −50.6% of holding | |
| Sheena Jonathan 6 fills | Director | Sell 10b5-1 | 3,150 | $354.19 | $1.1M | 224,264 −1.4% of holding | |
| Rabinowitz Matthew 14 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 52,000 | $347.29 | $18.1M | 2,173,913 −2.3% of holding | |
| Sheena Jonathan | Director | Sell 10b5-1 | 6,000 | $350.07 | $2.1M | 224,464 −2.6% of holding | |
| Rabinowitz Matthew 15 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 50,000 | $334.76 | $16.7M | 2,223,857 −2.2% of holding | |
| Rabinowitz Matthew 6 fills | EXECUTIVE CHAIRMAN | Sell 10b5-1 | 50,000 | $327.97 | $16.4M | 2,274,594 −2.2% of holding | |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell 10b5-1 | 15,160 | $326.89 | $5.0M | 110,859 −12% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.